Biohaven Pharmaceutical Holding Company Ltd. (BHVN) stock is rising. Here’s why?

The stock of Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) has risen on strong sales for a new migraine drug. The price of BHVN stock increased 13.56% on July 7 to $112.25 and rose 2.24% to $114.77 on Thursday, July 8.


Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.

Sponsored


Biohaven Pharmaceutical Holding Company Ltd. (BHVN) recently announced that its Nurtec Odt drug has generated $200 million in revenues since it began selling the product in the US in March 2020, while drug sales are growing and its potential commercially hasn’t been exhausted. Hence, the drug brought in $93 million in the second quarter of 2021.

The optimism of the company’s management and shareholders is based on Nurtec Odt’s capabilities. The drug is intended to prevent attacks of severe headache, not only to relieve symptoms once they appear. There are obvious benefits for patients in using this approach.

The target market for Nurtec Odt is very large since migraine has grown to become the world’s third-most prevalent disease. There are 40 million patients diagnosed with it in the United States alone, and it is one of the ten most common causes of disability.

The new drug provides the BHVN with an opportunity to grow its sales as more doctors and patients become aware of a new product. Currently, Nurtec Odt is the only migraine medication approved both for the prevention of migraines and for the treatment of acute attacks. One dose can relieve a patient’s pain in just an hour, and the effect lasts for two days in many cases. In prophylaxis, 18 doses of drugs are taken per month on average. There are also different options that can be taken such as reducing the number of attacks during a given month.

In addition to advancing the lives of patients with debilitating neurological disorders and neuropsychiatric disorders, Biohaven offers best-in-class medicines in clinical trial stages.

Latest

The Chart for Block Inc. (SQ) Stock Is Flashing Mixed Signals

In the first quarter, large investment funds expanded their...

What to Expect When Snap Inc. (SNAP) Reports Quarterly Earnings?

Snapchat, a social media platform owned by Snap Inc....

Getting Sustainable Earnings? Movado Group Inc. (MOV)

Movado Group Inc. (NYSE: MOV), the owner of the...

Future Prospects Brighter For Red Cat Holdings Inc. (RCAT) Stock

The US Army has awarded Red Cat Holdings, Inc....

Newsletter

 

Don't miss

Healthy Upside Potential: Maxar Technologies Ltd. (MAXR)

In May 25 trading, shares of space business Maxar...

Atkore Inc. (ATKR) stock: Better Than You Think

Atkore Inc. (NYSE:ATKR), a manufacturer of infrastructure, electrical, and...

Provention Bio, Inc. (PRVB) Having a Robust Premarket After Abysmal Thursday

Provention Bio, Inc. (PRVB), a clinical stage biopharmaceutical company,...

Farmmi, Inc. (FAMI) Stock Soaring in Premarket, Here’s the Reason

Farmmi, Inc. (FAMI), a company that processes and sells...

Ulta Beauty Inc. (ULTA) last month performance of -6.16% certainly makes it a sizzling prospect

Ulta Beauty Inc. (NASDAQ: ULTA) open the trading on May 26, 2022, with great promise as it jumped 7.09% to $377.96. During the day,...

The key reasons why Alset EHome International Inc. (AEI) is -95.54% away from 52-week high?

Witnessing the stock’s movement on the chart, on May 26, 2022, Alset EHome International Inc. (NASDAQ: AEI) set off with pace as it heaved...

StoneCo Ltd. (STNE) latest performance of 2.97% is not what was on cards

StoneCo Ltd. (NASDAQ: STNE) established initial surge of 2.97% at $9.71, as the Stock market unbolted on May 26, 2022. During the day, the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here